
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : SOB100
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Shine-On BioMedical
Deal Size : Undisclosed
Deal Type : Collaboration
Esco Aster Inks Exosome Manufacturing Deal with Shine-On Biomedical for HLA-G Drug Delivery Platform
Details : The collaboration aims to advance SOB100 for the treatment of solid tumors by targeting HLA-G.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
December 15, 2025
Lead Product(s) : SOB100
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Shine-On BioMedical
Deal Size : Undisclosed
Deal Type : Collaboration
